Rani Therapeutics Holdings (RANI) Long-Term Debt Repayments (2024 - 2025)
Rani Therapeutics Holdings' (RANI) quarterly Long-Term Debt Repayments came in at $9.5 million in Q4 2025, up 152.59% year-on-year from $3.8 million in Q4 2024, and up 152.59% quarter-over-quarter from $3.8 million in Q3 2025.
Rani Therapeutics Holdings (RANI) Long-Term Debt Repayments (2024 - 2025) Analysis & Trends
Rani Therapeutics Holdings' Long-Term Debt Repayments history runs 2 years deep, the most recent figure standing at $9.5 million for Q4 2025.
- On a quarterly basis, Long-Term Debt Repayments rose 152.59% year-over-year to $9.5 million in Q4 2025; TTM through Mar 2026 was $17.0 million, a 93.97% increase from a year earlier, with the FY2025 full-year figure at $20.7 million, up 314.44% from the prior year.
- Long-Term Debt Repayments climbed to $9.5 million in Q4 2025 per RANI's latest filing, from $3.8 million in the prior quarter.
- Across five years, Long-Term Debt Repayments topped out at $9.5 million in Q4 2025 and bottomed at $1.2 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.64 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Rani Therapeutics Holdings | 160.20 Mn | 167.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9.47 Mn |
| Dec 31, 2025 | 9.47 Mn |
| Sep 30, 2025 | 3.75 Mn |
| Sep 30, 2025 | 3.75 Mn |
| Jun 30, 2025 | 3.75 Mn |
| Jun 30, 2025 | 3.75 Mn |
| Mar 31, 2025 | 3.75 Mn |
| Mar 31, 2025 | 3.75 Mn |
| Dec 31, 2024 | 3.75 Mn |
| Dec 31, 2024 | 3.75 Mn |
| Sep 30, 2024 | 1.25 Mn |
| Sep 30, 2024 | 1.25 Mn |